Changes in Stereotypical Behavior Following Chlorpromazine Termination: Polypharmcy Effects on Response Class...

Area of Science:

• Neuroscience
• Developmental Psychology
• Psychopharmacology

Background:

• Stereotypical behaviors are common in developmental disabilities like autism spectrum disorder (ASD) and intellectual disability (ID).
• Limited research explores how psychotropic medications influence stereotypy in these populations.
• Understanding these interactions is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the impact of psychotropic medication changes on specific stereotypies in an individual with ASD and ID.
• To explore potential biological mechanisms, such as dopamine receptor activity, underlying observed behavioral changes.

Main Methods:

• A 2-year observational study of stereotypy (walking in circles, head tapping, arm flinging, object stereotypy) in one participant with ASD and ID.
• Participant received daily chlorpromazine, lorazepam, and divalproex.
• Chlorpromazine was discontinued at Week 75, while other medications were maintained.

Main Results:

• A statistically significant decrease in the frequency of walking in circles was observed after chlorpromazine discontinuation.
• No significant changes were noted in other stereotyped behaviors, including head tapping, arm flinging, or object stereotypy.

Conclusions:

• Chlorpromazine discontinuation differentially affected gross motor stereotypies, specifically walking in circles.
• Results suggest that alterations in dopamine receptor binding may selectively influence certain types of stereotypical responding.